Data for the article "Single-cell eQTL analysis identifies genetic variation underlying metabolic dysfunction-associated steatohepatitis"
Fuente:
Zenodo
Enregistré dans:
| Auteurs principaux: | Hong, Sung Eun, Suh, Kyung-Suk, Kim, Won, Choi, Murim |
|---|---|
| Format: | Recurso digital |
| Publié: |
Zenodo
2025
|
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Context-dependent nature of eQTL analysis
par: Wang, Zhongju
Publié: (2025)
par: Wang, Zhongju
Publié: (2025)
Hepatopulmonary syndrome as presentation of pediatric metabolic dysfunction‐associated steatohepatitis
par: Shruti Sakhuja, et autres
Publié: (2026)
par: Shruti Sakhuja, et autres
Publié: (2026)
Performance of MAST, FAST, and MEFIB in predicting metabolic dysfunction‐associated steatohepatitis
par: Shi Qi, et autres
Publié: (2024)
par: Shi Qi, et autres
Publié: (2024)
Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?
par: Stergios A. Polyzos, et autres
Publié: (2026)
par: Stergios A. Polyzos, et autres
Publié: (2026)
Targeted plasma eQTL and pQTL analyses to identify potential novel biomarkers for Alzheimer's Disease in African Americans
par: Vanessa M. Colón Badillo, et autres
Publié: (2025)
par: Vanessa M. Colón Badillo, et autres
Publié: (2025)
The adiponectin‐derived peptide ALY688 protects against the development of metabolic dysfunction‐associated steatohepatitis
par: Zhe Huang, et autres
Publié: (2024)
par: Zhe Huang, et autres
Publié: (2024)
Semaglutide improves metabolic dysfunction‐associated steatohepatitis: A 10‐year retrospective study
par: Parth Shah, et autres
Publié: (2024)
par: Parth Shah, et autres
Publié: (2024)
A review of multidisciplinary care in metabolic dysfunction‐associated steatohepatitis and cardiometabolic disease, with a focus on Canada
par: James Kim, et autres
Publié: (2025)
par: James Kim, et autres
Publié: (2025)
Identification of salt tolerance‐associated presence–absence variations in the OsMADS56 gene through the integration of DEGs dataset and eQTL analysis
par: Yuchao Cui, et autres
Publié: (2024)
par: Yuchao Cui, et autres
Publié: (2024)
wtsi-hgi/QTLight: QTLight v1.61 – Flexible eQTL Mapping with LIMIX, TensorQTL, and SAIGE-QTL
par: Matiss, et autres
Publié: (2025)
par: Matiss, et autres
Publié: (2025)
One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis and fibrosis in high‐risk population
par: Paula Iruzubieta, et autres
Publié: (2024)
par: Paula Iruzubieta, et autres
Publié: (2024)
Molecular pathogenesis of metabolic dysfunction‐associated steatotic liver disease, steatohepatitis, hepatic fibrosis and liver cirrhosis
par: Takashi Saito, et autres
Publié: (2024)
par: Takashi Saito, et autres
Publié: (2024)
Using Importance Sampling to Estimate $p$-values in All-Subset Meta-Analysis, with Applications to Single-Cell eQTL Mapping
par: Anyaso-Samuel, Samuel, et autres
Publié: (2026)
par: Anyaso-Samuel, Samuel, et autres
Publié: (2026)
Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography
par: Myung Jin Kim, et autres
Publié: (2024)
par: Myung Jin Kim, et autres
Publié: (2024)
Hepatic thyroid hormone receptor‐β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction‐associated steatohepatitis
par: Stergios A. Polyzos, et autres
Publié: (2024)
par: Stergios A. Polyzos, et autres
Publié: (2024)
Use of non‐invasive diagnostic tools for metabolic dysfunction‐associated steatohepatitis: A qualitative exploration of challenges and barriers
par: Emmanuel A. Tsochatzis, et autres
Publié: (2024)
par: Emmanuel A. Tsochatzis, et autres
Publié: (2024)
Dynamic changes of gut microbiota in mouse models of metabolic dysfunction‐associated steatohepatitis and its transition to hepatocellular carcinoma
par: Yu‐Li Wang, et autres
Publié: (2024)
par: Yu‐Li Wang, et autres
Publié: (2024)
GWAS and eQTL analyses reveal genetic components influencing the key fiber yield trait lint percentage in upland cotton
par: Chunping Guo, et autres
Publié: (2025)
par: Chunping Guo, et autres
Publié: (2025)
Inhibition of intracellular versus extracellular cathepsin D differentially alters the liver lipidome of mice with metabolic dysfunction‐associated steatohepatitis
par: Isabeau Vermeulen, et autres
Publié: (2024)
par: Isabeau Vermeulen, et autres
Publié: (2024)
The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH)
par: Iskandar Idris
Publié: (2024)
par: Iskandar Idris
Publié: (2024)
Efsubaglutide Alfa attenuates metabolic dysfunction‐associated steatohepatitis in mice with improvements in second harmonic generation‐derived fibrosis features
par: Yahao Wang, et autres
Publié: (2026)
par: Yahao Wang, et autres
Publié: (2026)
Properties of Carbon-rich Asymptotic Giant Branch Stars in the LMC and the Milky Way
par: Suh, Kyung-Won
Publié: (2025)
par: Suh, Kyung-Won
Publié: (2025)
Infrared Variability of Carbon Stars in the LMC Observed with NEOWISE-R
par: Suh, Kyung-Won
Publié: (2025)
par: Suh, Kyung-Won
Publié: (2025)
Infrared properties of carbon stars in our Galaxy
par: Suh, Kyung-Won
Publié: (2024)
par: Suh, Kyung-Won
Publié: (2024)
AGB and Post-AGB Stars versus Planetary Nebulae and Young Stellar Objects: Properties in Visual and IR Bands
par: Suh, Kyung-Won
Publié: (2024)
par: Suh, Kyung-Won
Publié: (2024)
The associations between fibrosis changes and liver‐related events in patients with metabolic dysfunction‐associated steatotic liver disease
par: Hye Won Lee, et autres
Publié: (2024)
par: Hye Won Lee, et autres
Publié: (2024)
eQTL Analysis Elucidates the Genetic Basis Underlying Transgressive Gene Expression in Nelumbo Hybrids
par: Zhiyan Gao, et autres
Publié: (2025)
par: Zhiyan Gao, et autres
Publié: (2025)
APOE‐ε4 interacts with the BTBD7 testis‐eQTL to reduce longevity in males
par: Junyoung Park, et autres
Publié: (2024)
par: Junyoung Park, et autres
Publié: (2024)
Sex reporting of cells used in cancer research: A systematic review
par: Mi‐Na Park, et autres
Publié: (2024)
par: Mi‐Na Park, et autres
Publié: (2024)
Integrated Analysis of Bulk RNA Sequencing, eQTL, GWAS, and Single‐Cell RNA Sequencing Reveals Key Genes in Hepatocellular Carcinoma
par: Mingkai Gong, et autres
Publié: (2025)
par: Mingkai Gong, et autres
Publié: (2025)
Technology Infusion Analysis‐Based Research and Development Project Portfolio Valuation
par: Hojin Jang, et autres
Publié: (2025)
par: Hojin Jang, et autres
Publié: (2025)
Enhanced hepatoprotective effects of empagliflozin and vitamin D dual therapy against metabolic dysfunction‐associated steatohepatitis in mice by boosted modulation of metabolic, oxidative stress, and inflammatory pathways
par: Wesam F. Farrash, et autres
Publié: (2024)
par: Wesam F. Farrash, et autres
Publié: (2024)
Integrating Genomic, eQTL, and Mendelian Randomization Analyses to Identify Microglial Drug Targets in Multiple Sclerosis
par: Wu Yan, et autres
Publié: (2025)
par: Wu Yan, et autres
Publié: (2025)
Providing biological context for GWAS results using eQTL regulatory and co‐expression networks in Populus
par: Mengjun Shu, et autres
Publié: (2024)
par: Mengjun Shu, et autres
Publié: (2024)
Mendelian randomization analysis using GWAS and eQTL data to investigate the relationship between chronotype and neuropsychiatric disorders and their molecular basis
par: Shane Crinion, et autres
Publié: (2024)
par: Shane Crinion, et autres
Publié: (2024)
Glucose metabolism partially regulates β‐cell function through epigenomic changes
par: Yong Kyung Kim, et autres
Publié: (2024)
par: Yong Kyung Kim, et autres
Publié: (2024)
Identification of growth differentiation factor 15 as an early predictive biomarker for metabolic dysfunction‐associated steatohepatitis: A nested case–control study of UK Biobank proteomic data
par: Hao Wang, et autres
Publié: (2025)
par: Hao Wang, et autres
Publié: (2025)
Advances in Exploring Mechanisms of Oxidative Phenolic Coupling Reactions
par: Haeun Choi, et autres
Publié: (2024)
par: Haeun Choi, et autres
Publié: (2024)
Are we ready for genetic testing in metabolic dysfunction‐associated steatotic liver disease?
par: Adele Tulone, et autres
Publié: (2024)
par: Adele Tulone, et autres
Publié: (2024)
Validation of a whole slide image management system for metabolic‐associated steatohepatitis for clinical trials
par: Hanna Pulaski, et autres
Publié: (2024)
par: Hanna Pulaski, et autres
Publié: (2024)
Documents similaires
-
Context-dependent nature of eQTL analysis
par: Wang, Zhongju
Publié: (2025) -
Hepatopulmonary syndrome as presentation of pediatric metabolic dysfunction‐associated steatohepatitis
par: Shruti Sakhuja, et autres
Publié: (2026) -
Performance of MAST, FAST, and MEFIB in predicting metabolic dysfunction‐associated steatohepatitis
par: Shi Qi, et autres
Publié: (2024) -
Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?
par: Stergios A. Polyzos, et autres
Publié: (2026) -
Targeted plasma eQTL and pQTL analyses to identify potential novel biomarkers for Alzheimer's Disease in African Americans
par: Vanessa M. Colón Badillo, et autres
Publié: (2025)